Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL)

CAPS Rating: 2 out of 5

A specialty biopharmaceutical company with a focus on developing and marketing products to urologists, endocrinologists, orthopedists and select primary care physicians.

Recs

0
Player Avatar hlacheen (99.16) Submitted: 2/14/2007 12:32:08 AM : Underperform Start Price: $14.54 AUXL Score: -35.67

Another crappy pharmaceutical company that will never earn a profit.

Featured Broker Partners


Advertisement